These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 947380)

  • 21. The inherent characteristics and DNA polymorphism of Vibrio cholerae and other vibrios.
    Wang J; Li Y; Shi J; Li L; Bai W; Yu A; Jiang S
    Chin Med J (Engl); 2002 Apr; 115(4):589-92. PubMed ID: 12133305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological profile of outbreaks of cholera in India during 1975-1989.
    Datta KK; Singh J
    J Commun Dis; 1990 Sep; 22(3):151-9. PubMed ID: 2098418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wind direction and its linkage with Vibrio cholerae dissemination.
    Paz S; Broza M
    Environ Health Perspect; 2007 Feb; 115(2):195-200. PubMed ID: 17384764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term survival of E1 Tor cholera vibrios in naturally contaminated sewage].
    Zaĭdenov AM; Saiamov RM; Maloletkov IS; Lazorenko NF; Bichul' KG
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):61-5. PubMed ID: 1024446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemic and endemic cholera trends over a 33-year period in Bangladesh.
    Longini IM; Yunus M; Zaman K; Siddique AK; Sack RB; Nizam A
    J Infect Dis; 2002 Jul; 186(2):246-51. PubMed ID: 12134262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
    Chaicumpa W; Chaisri U; Tapchaisri P; Chongsa-Nguan M; Pongponratn E
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological conversion of Vibrio chorlerae in gnotobiotic mice.
    Miller CE; Wong KH; Feeley JC; Forlines ME
    Infect Immun; 1972 Nov; 6(5):739-42. PubMed ID: 4564785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Makeup of a population El Tor vibrios according to their agglutinability by type-specific sera].
    Somova AG; Lobanova LN; Badalova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):82-5. PubMed ID: 34303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applied studies on the viability of El Tor vibrios.
    Pesigan TP; Plantilla J; Rolda M
    Bull World Health Organ; 1967; 37(5):779-86. PubMed ID: 4870081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delayed hypersensitivity in the chronic cholera vibrio carrier state in animals with an absence of normal microflora].
    Gorskaia EM; Chakhava OV; Rubtsov IV; Gaĭlonskaia IN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):64-8. PubMed ID: 7445851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae.
    Sack RB; Miller CE
    J Bacteriol; 1969 Sep; 99(3):688-95. PubMed ID: 5370274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virulence of V. cholerae strains, isolated from carriers, in the rabbit ileal loop.
    Sinha R; Deb BC; Ghosh AK; Shrivastava DL
    Indian J Med Res; 1969 Sep; 57(9):1636-40. PubMed ID: 5369789
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of orally administered pancreatic extract on Vibrio cholerae infection during protein deficiency].
    Gyr K; Felsenfeld O
    Schweiz Med Wochenschr; 1977 Apr; 107(15):545-6. PubMed ID: 404703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriological studies of convalescent carriers of cholera vibrios.
    Pierce NF; Banwell JC; Gorbach SL; Mitra RC; Mondal A; Manji PM
    Indian J Med Res; 1969 Apr; 57(4):706-12. PubMed ID: 5805373
    [No Abstract]   [Full Text] [Related]  

  • 37. Antagonism against Vibrio cholerae by diffusible substances produced by bacterial components of the human faecal microbiota.
    Silva SH; Vieira EC; Dias RS; Nicoli JR
    J Med Microbiol; 2001 Feb; 50(2):161-164. PubMed ID: 11211223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tropical sprue in gnotobiotic rats?
    Klipstein FA; Goetsch CA; Engert RF; Short HB; Schenk EA
    Gastroenterology; 1979 May; 76(5 Pt 1):1082-3. PubMed ID: 437415
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimentally induced cholera in guinea pigs. I. Elaboration of the method of infection].
    Kotenok IaF; Urakov NN
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):84-7. PubMed ID: 1007732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gallbladder damage and prolonged excretion of cholera vibrios in Erythrocebus patas.
    Greer WE; Jiricka Z; Felsenfeld O
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):551-5. PubMed ID: 4967028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.